Clinical Trial: The efficacy and safety of neoadjuvant Sintilimab plus chemotherapy followed by surgery versus concurrent chemoradiotherapy for limited-stage small cell lung cancer (China)

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The efficacy and safety of neoadjuvant Sintilimab plus chemotherapy followed by surgery versus concurrent chemoradiotherapy for limited-stage small cell lung cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129772

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Cancer Hospital of Shandong First Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337484

Published by HT Digital Content Services with permission from Health Daily Digest....